Wells Fargo’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Buy |
|
|||||
|
2025
Q1 | $625K | Sell |
|
|||||
|
2024
Q4 | $1.28M | Sell |
|
|||||
|
2024
Q3 | $1.85M | Buy |
|
|||||
|
2024
Q2 | $1.19M | Sell |
|
|||||
|
2024
Q1 | $1.47M | Sell |
|
|||||
|
2023
Q4 | $2M | Sell |
|
|||||
|
2023
Q3 | $2.17M | Buy |
|
|||||
|
2023
Q2 | $1.92M | Sell |
|
|||||
|
2023
Q1 | $1.67M | Buy |
|
|||||
|
2022
Q4 | $488K | Buy |
|
|||||
|
2022
Q3 | $333K | Sell |
|
|||||
|
2022
Q2 | $677K | Buy |
|
|||||
|
2022
Q1 | $383K | Buy |
|
|||||
|
2021
Q4 | $282K | Sell |
|
|||||
|
2021
Q3 | $500K | Sell |
|
|||||
|
2021
Q2 | $5.48M | Sell |
|
|||||
|
2021
Q1 | $8.41M | Sell |
|
|||||
|
2020
Q4 | $11.7M | Buy |
|
|||||
|
2020
Q3 | $3.39M | Sell |
|
|||||
|
2020
Q2 | $4.62M | Buy |
|
|||||
|
2020
Q1 | $1.55M | Sell |
|
|||||
|
2019
Q4 | $2.18M | Buy |
|
|||||
|
2019
Q3 | $1.65M | Sell |
|
|||||
|
2019
Q2 | $5.06M | Sell |
|
|||||
|
2019
Q1 | $5.64M | Buy |
|
|||||
|
2018
Q4 | $1.13M | Buy |
|
|||||
|
2018
Q3 | $1.81M | Buy |
|
|||||
|
2018
Q2 | $1.73M | Sell |
|
|||||
|
2018
Q1 | $1.23M | Buy |
|
|||||
|
2017
Q4 | $1.07M | Sell |
|
|||||
|
2017
Q3 | $2.49M | Sell |
|
|||||
|
2017
Q2 | $16.2M | Sell |
|
|||||
|
2017
Q1 | $38.1M | Sell |
|
|||||
|
2016
Q4 | $53.8M | Buy |
|
|||||
|
2016
Q3 | $52.2M | Sell |
|
|||||
|
2016
Q2 | $65.9M | Sell |
|
|||||
|
2016
Q1 | $109M | Sell |
|
|||||
|
2015
Q4 | $199M | Buy |
|
|||||
|
2015
Q3 | $150M | Buy |
|
|||||
|
2015
Q2 | $84.8M | Buy |
|
|||||
|
2015
Q1 | $690K | Buy |
|
|||||
|
2014
Q4 | $96K | Buy |
|
|||||
|
2014
Q3 | $35K | Sell |
|
|||||
|
2014
Q2 | $37K | Buy |
|
|||||
|
2014
Q1 | $21K | Buy |
|